Leisure, Lifestyle & Wellness
Are drug companies the cause of death of AIDS patients?

No one to date has shown that the HIV virus is the sole cause of AIDS. Apart from propaganda by drug companies, anti-viral drugs have not been shown to have made an impact on AIDS

I am in total agreement with Richard Smith, the wise former editor of the British Medical Journal, who recently wrote that free speech is a pre-requisite for any progress in connection with the AIDS controversy. Just as Milton had said in the past, the Nobel Laureate Indian poet, Rabindranath Tagore, had said in his Nobel winning poem Geetanjali that for wisdom to dawn on mankind man must live in a world where knowledge flows freely without any restrictions whatsoever. Another Nobel Laureate, Kary Mullis, the father of the PCR test, writing the foreword for the book Inventing the AIDS Virus by a noted virologist, Peter H Duesberg, his colleague at the Berkley University, has this to say about the AIDS drama. Kary should know better as the PCR test is the one that everyone uses to detect viruses.

 “I like and respect Peter Duesberg. I don’t think he knows necessarily what causes AIDS; we have disagreements about that. But we’re both certain about what doesn’t cause AIDS.  We have not been able to discover any good reasons why most of the people on earth believe that AIDS is a disease caused by a virus called HIV. There is simply no scientific evidence demonstrating that this is true.  …we have also been not able to discover why doctors prescribe a toxic drug called Zidovudine to people who have no other complaint than the presence of anti-bodies to HIV in their blood. We wonder why humans take that drug for any reason…”  Is this book a myth or are we all barking up the wrong tree? Read the following recent quotes. Pity is that Luc Montagnier has already received the Nobel!!

“Canadian filmmaker Brent Leung isn't winning any friends in the pharmaceutical industry these days. His breakthrough documentary ‘House of Numbers’ features jaw-dropping interviews with doctors, researchers and even the co-discoverer of HIV himself (Luc Montagnier), all of whom reveal startling information calling into question the ‘official’ explanation of HIV and AIDS.”

“So how on earth did it become the big boogey man virus of the world? The person who announced that HIV caused AIDS was an American, Dr Robert Gallo. He has since been accused of professional misconduct, his test has been exposed as fraudulent, and two of his laboratory executives have been convicted of criminal offenses. Tens of millions of people are tested for HIV antibodies every year and Dr Gallo, who patented his ‘test’, gets a royalty for every one.”

“Luc Montagnier, Gallo’s partner in the HIV-causes-AIDS theory, has since admitted in 1989: ‘HIV is not capable of causing the destruction of the immune system which is seen in people with AIDS’. Nearly 500 scientists across the world agree with him. So does Dr Robert E Wilner, author of the book ‘The Deadly Deception. The Proof That Sex And HIV Absolutely Do Not Cause AIDS’.”

“Dr Wilner even injected himself with the HIV virus on a television chat show in Spain to support his claims. Other doctors and authors come to the same conclusions, among them Peter Duesberg PhD and John Yiamouyiannis PhD, in their book, ‘AIDS: The Good News Is That HIV Doesn’t Cause it. The Bad News Is ‘Recreational Drugs’ And Medical Treatments like AZT Do’. That’s a long title, but it sums up the situation. People are dying of AIDS because of the treatments used to ‘treat’ AIDS!”

This brings to mind the infamous story of Beriberi. In a paper in the famous The Lancet in 1887, Kanehiro Takaki refuted the bacteria hunters’ claim that beriberi was due to a bacterium and showed that it is due to diet deficiency. He was laughed at in the beginning. Similar is the story of the SMON fiasco. SMON was a frightening disease that struck Japan in the 1950s when the polio epidemic was raging and quickly it was declared to be a viral disease by many virus hunters. After hundreds of SMON sufferers died both in Japan and other countries including India, the real cause was found out. It might be coincidence that Gajdusek published his findings that SMON (Sub-acute Myelo-optico-neuropathy) was due to slow virus in the famous journal Nature and was lauded by his fellow virologists. Another virus discovery came from the Middlesex Hospital in 1964!  Finally, this syndrome was shown to be due to the side effects of a then commonly used anti-diarrhoeal drug clinoquinol!  Friends, let us not be deluded easily.

“And see, no longer blinded by our eyes”—Rupert Brooke.

William Shakespeare was dead right when he wrote that the whole world is but a drama stage. Most of what we see or hear are myths. Recently, we have had the World AIDS Day. It was celebrated with much fanfare all over. Next we would think seriously of AIDS a year later. In the meantime the drama goes on backstage where drug companies and technology companies play their part in creating the claptrap that AIDS is going to annihilate mankind on this planet and the panacea for that are the drugs sold by them. Philanthropes pour their money into the drug company kitty to have a clear conscience! Drug companies have the last laugh, though.

Most of us buy that argument without going into the real truth of the matter as we do not have the wherewithal to do so and the ones that have, per force, to go deep into the real world have no inclination or time to do so. Lately medical education of students, as also the continuing education of doctors, is being funded by the drug companies. The latter do not believe in free lunch, anyway. In America this has been elegantly shown to be true to the extent that even the text books were written with the help of drug company money. Medical research relies on funding from these agencies with all government funding drying up everywhere. Naturally, the funding agencies would want to see what they want to see in medical research resulting in the medical world believing in this kind of half truths and falsehood.

We in India have been recently bombarded with the frightening news that most of the major killers like heart attacks, high blood pressure, and diabetes are going to come here in a very big way and most of us, if not all of us, are in danger unless we go with the establishment to get ourselves routinely checked up for all those maladies and take the drugs suggested by them! There is no truth in any one of the above statements. None of them is based on sound scientific validation. Epidemiology is a very imprecise science when applied to chronic diseases, although in the past it has served the limited purpose during the epidemics of contagious diseases. Most of the above propaganda of predicting the unpredictable chronic illness scenario for the future is only the hype created by the vested interests to make money. If these predictions are really true there would be no well man in the world!

AIDS is not a disease. Rather, it is a syndrome—a conglomeration of symptoms and signs—seen in certain patients who have many other things in common. Every syndrome has multiple facets. There is no direct one-to-one cause-effect relationship in any syndrome. In the AIDS syndrome drama, probably, the HIV virus could be the hero, but there are the heroine and other actors who are as important, if not more important, than the hero for the final outcome. No human illness should be viewed through a reductionist glass. Although the AIDS syndrome was first described way back in 1981 in two homosexual males, one in San Fransisco and the other in Paris, having similar clinical presentations and sure death, no one to date has shown that the HIV virus is the sole cause of AIDS. For the first time the announcement of a new disease in the scientific world came through a press conference and not through any scientific study published in a good peer-reviewed journal. Of course, lately lot of so-called researchers are jumping on to the AIDS bandwagon, mainly because the US National Institute of Health annual budget for AIDS research is $8 billion, while the cancer budget for the same period, is only $2 billion! “When it is a question of money, everybody is of the same religion” wrote the great French philosopher Voltaire. Scientists are no exception.

The drama of AIDS syndrome starts with poverty which is the mother of all illnesses. The poor and the very poor in the third world countries, especially Africa, are the worst hit. They have very little to eat and, consequently, have very low blood protein levels. Proteins are the antibodies to fight any disease. “Any disease is directly related to the virulence of the cause but inversely related to the resistance of the host,” wrote Theobald Smith, an American physician, in the year 1915. That was the beginning of the new science of host resistance, now called immunology. Up until that time the medical world was lost in the Koch’s postulates where the disease was caused by a germ. The host factor was not taken into consideration. Immunology progressed at a breath-taking speed only after white homosexuals died in 1981 with depressed immune systems.

Next to poverty, the other actors in the depressed immune system drama are the lifestyles that modern man has adopted for himself. Drug addiction, even tobacco and alcohol are bad drugs, unnatural sex habits—anal and oral sex—could depress the immune system by depositing the highly antigenic human semen into the gut, are the other actors! Many of the therapeutic drugs that we doctors give on long-term basis for chronic diseases add to the burden. Fear, extreme fear at that, could also depress the immune system. Therefore, in the AIDS drama there are many powerful actors that dictate the final outcome and not the HIV family of viruses alone.

In fact, the HIV viruses, probably, do not play such a major role. This was indirectly shown by the recent revelation that some of the prostitutes that have been in constant business in their trade have been strongly positive for the HIV virus antibodies since 1981. They are in robust health, though! Many of them have healthy children too. Saloma Khatoumi, a Nigerian, aged 42 years, is one such example. She has been servicing about 10-15 customers per night and has been HIV positive for decades but in good health. She has one healthy child, too. It is from her blood that the Oxford AIDS researchers found a peculiar phenomenon that a variant of the HIV virus could improve the immune functions! The Oxford Group has since produced a vaccine based on this knowledge. This vaccine is undergoing pilot trials and could be available for human use in the next decade or so.

The story of the anti-AIDS drugs has not been any different from many other anti-microbial drugs. Each one, from the first Sulpha and penicillin to the latest drug, has had a huge advertisement about its efficacy and its capacity to save lives. The truth, however, is that most of them have now created the monster of drug-resistant germs, called super bugs, that threaten to annihilate mankind on this planet, unless we wake up and do something about it. Not a single germ-related disease has been conquered by anti-microbial drugs to date. The only disease that man was able to eradicate, small pox, was done by vaccination that was in use in India for “times out of mind”. The saving grace would be the immune boosters that Indian medical systems had for thousands of years in use. The good news is that the Indian Council for Scientific and Industrial Research has been able to patent a very powerful immune booster derived from cow’s urine lately. Immune boosters would be the future panacea for immune depression syndromes of all hues.

“History repeats itself; if you do not learn from history you will have to relive history,” wrote Cicero, the great Roman thinker. India has learnt a very bad lesson in the past in the area of anti-TB drugs. Let us not repeat that with anti-AIDS drugs! Dr JR Bignall, one of the world’s greatest TB specialists, was invited by our government in 1956 to advice us about the TB scenario in the country. A few anti-TB drugs were intermittently available at that time. Bignall studied the disease pattern exhaustively and advised the government not to let those anti-TB drugs be used here for at least ten years! His argument was that if we get those drugs the use of the drugs will be irregular and that might produce-resistant germs of TB. If drugs are not used and the patients given proper food and sanitation, those that survive would get better and the germ dies in them because of the immune system. Those that are very bad would die anyway and the germ also dies with them, buried or burnt. In either case in the following ten years TB germs would almost disappear from India. But he said that detection and isolation was of paramount importance along with the sanatorium line of management.

The powers-that-be at that time ignored the report and today we have a huge amount of resistant TB in India that we will not be able to tackle. AIDS will pale into insignificance when you think of the ravages that the White Death (TB) caused in this world. It was worse than the Black Death of plague! Similar and still worse will be the fate of anti-viral drugs in AIDS. In the first place all anti-viral drugs are partially effective. They have serious side effects that the drug might kill quite a FEW victims. Apart from the drug company propaganda and education these drugs have not been shown to have made an impact on AIDS. What would make an impact is health promotion in our poor people. Good food, clean water, a roof on top of their heads, a toilet for every house to avoid the ravages of hookworms, and health education regarding safe sex, drug addiction, alcohol and tobacco would save millions of lives in the future.

There is no pill for every ill, but there is a definite ill following every pill
. Only a holistic view would be beneficial. I am wondering as to when modern medicine would realize its folly and follow the correct science of holism, non-linear mathematics and the science of CHAOS. God save the poor people.

“Science is always wrong. It never solves a problem without creating new ones”—George Bernard Shaw

(Professor Dr BM Hegde, a Padma Bhushan awardee in 2010, is an MD, PhD, FRCP (London, Edinburgh, Glasgow & Dublin), FACC and FAMS. He is also Editor-in-Chief of the Journal of the Science of Healing Outcomes, Chairman of the State Health Society's Expert Committee, Govt of Bihar, Patna. He is former Vice Chancellor of Manipal University at Mangalore and former professor for Cardiology of the Middlesex Hospital Medical School, University of London. Prof Dr Hegde can be contacted at [email protected])




4 years ago

Birth control would help India's poor people more than anything else.

Equity mutual funds witness net outflow for the fifth consecutive month

The net outflows from equity mutual fund schemes at Rs1,984 crore, which peaked to their highest in two years in September 2012, continued for the fifth straight month

The mutual fund reforms that came into force from 1st October didn’t seem to have a positive impact yet on the industry. The new regulations triggered a flurry of activity among both, fund houses and investors. Fund houses were busy implementing the single plan structure wherein the regulator has mandated the fund houses to have a single plan under all their schemes. This has led to the withdrawal of systematic investments and dividend reinvestments under plans of existing schemes that have been discontinued. Along with this, the increase in expense ratio allowed to be charged has had no effect. New inflows into equity schemes declined even further. The new inflows could not match with the redemptions, leading to a net outflow of Rs1,984 crore, according to monthly data from The  Association  of  Mutual  Funds  in  India (AMFI).

Also Read: Best Equity Mutual Funds for Any Season

Moneylife has written in the past how the Securities and Exchange Board of India’s (SEBI) regulations seem geared to benefit asset management companies (AMCs) rather than investors.(Read: SEBI’s mutual fund rules changes are patently anti-investor) Considering this has been just the first month since the implementation it would be interesting to see if SEBI’s  new reforms would be able to “re-energise the mutual fund industry” in the coming months.

Sales, which had touched Rs3,385 crore in August 2012—the highest in seven months, has been on a decline ever since. Sales for the month of October reached just Rs3,072 crore. The additional incentive, in the form of higher expense ratio, has yet to create an impact on sales. Redemptions, though 25% lower than the previous month, were still higher the average redemptions seen April 2012 to July 2012.

To read more news and analysis about mutual funds from Moneylife, click here.

Equity assets under management (AUM) fell by 2% over the month from Rs1.87 lakh crore to Rs1.83 lakh crore while the Sensex declined by 1.37% over the same period. Equity AUM has declined by nearly 5% from May 2011 where the equity AUM stood at Rs1.92 lakh crore when the Sensex was at the same level compared to last month. Over the last few years equity mutual fund sales have struggled and redemptions continued. For CY 2012, equity mutual fund schemes have seen a total outflow of Rs12,377 crore. The highest such redemptions were seen in 2010.


Who were the winners and losers of the recently ended quarter? Here is an analysis




4 years ago

Mutual funds are investment vehicles for savings .
In a high inflationary scenario it is difficult to have savings .
INFACT to maintain the lifestyle we have to dip into our savings .
i have closed two of my accounts and if inflation does not fall i will have to redeem the balance also as the company has said no increments or bonus infact they may reduce workforce


4 years ago

There seems to be a popular perception in the ‘Ivory tower’ circles that mutual funds inflows would increase with rising equity markets. These pundits have been proven to be wrong so far as the equity markets have gone up by 20% approx. and with the rising markets more mutual fund investors have chosen to redeem than invest.

About 50% registered MF agents / distributors have gone out of business, now who is going to sell and bridge the widening gap & how?

It may already be too late now to realize that instead of stopping mis-selling, we may have succeeded in stopping sales in a very very big way – while doing nothing to penalize those who have indulged in client abuse by churning/mis-selling in the past.

Although investing in mutual funds is simple, past mobilization data would reveal not many like to invest directly on their own, but prefer going through an agent. Even the direct route offering 0.5% - 0.7% savings per annum may not be a game changer as envisaged. Though we can wait and the results will be there for all to see

A deeper look may actually reveal that while most people seek the services of an agent while investing, they may prefer redeeming mutual fund units by themselves, on their own depending mostly on their individual situation (need for funds). The number of folios has come down by about 2 million . . . who will win them back and how?

We will soon realize, that though the agents / distributors are the weakest link in the Mutual Funds ecosystem, they are also the most critical, as they are the ones who mobilize assets for the MF industry. If there are not enough assets what will the AMCs manage?

The ground realities shall finally prevail over the bird’s eye view. . .

BSE Sensex, Nifty still in a downtrend: Monday Closing Report

Nifty has to stay above 5,645 for the bulls to be hopeful

The market ended the last day of the Hindu calendar on a flat note weighed down by the decline in industrial production numbers for September and weak global cues. Today the Nifty hit a lower high and a lower low ended marginally in the negative. On Friday we had mentioned that the index may see further downward momentum if it closes below 5,645. We continue to maintain the stance. The National Stock Exchange (NSE) saw a volume of 64.22 crore shares and an advance decline ratio of 793:921.
The Indian market will hold a special ‘Muhurat’ trading session on Tuesday to welcome the Hindu New Year—Samvat 2069—and will remain closed on Wednesday. regular trading will resume on Thursday.
The Indian market opened with small gains ahead of the release of the industrial output data for September later in the day and weakness in the Asian markets which were mostly lower in morning trade on reports of a fall in Japan’s gross domestic product (GDP) to 0.9% in the September quarter and concerns about the US economy.
The Nifty opened two points up at 5,688 and the Sensex started off the day at 18,691, a gain of seven points over its previous close. Select buying in initial trade led the indices to their highs in the first half hour wherein the Nifty rose to 5,719 and the Sensex went up to 18,751.
However, the gains were short-lived as the benchmarks began paring early gains and edged lower. The disappointing Index of Industrial Production (IIP) data for September coming in at negative 0.4% compared to 2.3% in the previous month pushed the market into the red.
This apart, higher food prices pushed up retail inflation to 9.75% in October compared to 9.73% in the previous month. 
The market remained sideways in noon trade as benchmarks hovered on both sides of their previous closing levels. The lower opening of the key European markets kept the local indices in the red. The losses pushed the market to the day’s low. At that point, the Nifty fell to 5,666 and the Sensex went back to 18,608.
The market settled almost unchanged on a decline in IIP numbers for September and a weak trend across Asia. The Nifty shed three points to finish the session at 5,684 and the Sensex fell 13 points to 18,670.
While the Sensex settled with a negative bias, the broader markets were in the green. The BSE Mid-cap index gained 0.32% and the BSE Small-cap index rose 0.20%.
The main sectoral gainers were BSE Consumer Durables (up 1.13%); BSE Bankex (up 0.94%); BSE Realty (up 0.87%); BSE TECk (up 0.57%) and BSE IT (up 0.54%). The key losers were BSE Metal (down 0.70%); BSE Capital Goods (down 0.67%); BSE Oil & Gas (down 0.36%); BSE Auto (down 0.34%) and BSE Power (down 0.23%).
Eleven of the 30 stocks on the Sensex closed in the positive. The top gainers were HDFC Bank (up 1.85%); Bharti Airtel (up 1.63%); State Bank of India (up 1.59%); TCS (up 0.66%) and Infosys (up 0.48%). The major losers were Tata Steel (down 1.72%); Hero MotoCorp (down 1.67%); ITC (down 1.56%); Tata Power (down 1.43%) and Jindal Steel (down 0.95%).
The top two A Group gainers on the BSE were—United Spirits (up 34.93%) and L&T Finance Holdings (up 11.37%).
The top two A Group losers on the BSE were—United Breweries (down 4.48%) and Indian Hotels Company (down 3.77%).
The top two B Group gainers on the BSE were—BLS Infotech (up 20%) and Kamdhenu Ispat (up 20%).
The top two B Group losers on the BSE were—Raj Television (down 20%) and Somi Conveyor Beltings (down 19.75%).
Out of the 50 stocks listed on the Nifty, 24stocks settled in the positive. The chief gainers were IDFC (up 3.31%); HDFC Bank (up 2.15%); Jaiprakash Associates (down 2.03%); Bharti Airtel (up 1.69%) and SBI (up 1.57%). DLF (down 2.68%); Ranbaxy Laboratories (down 2.16%); Hero MotoCorp (down 2.03%); BPCL (down 2.01%) and Siemens (down 1.85%) settled at the bottom of the index.
Markets across Asia closed mostly in the red on the decline in Japanese GDP and economic concerns in the US. ON the other hand, the Chinese market received a boost from a higher trade surplus in October, which was the biggest in the past 45 months.
The Jakarta Composite declined 0.37%; the KLSE Composite fell 0.21%; the Nikkei 225 dropped 0.93%; the Straits Times shed 0.07%; the Seoul Composite lost 0.19% and the Taiwan Weighted settled 0.35% down. Among the gainers, the Shanghai Composite climbed 0.49% and the Hang Seng rose 0.21%.
At the time of writing, the European indices that opened in the red were mixed while the US stock futures were in the positive.
Back home, institutional investors—both foreign and domestic—were net sellers of stocks on Friday. Foreign institutional investors withdrew funds totalling Rs204.25 crore and domestic institutional investors pulled out Rs154.01 crore.
Mumbai-based DCB Bank today said its board has approved a preferential allotment Rs93 lakh shares to two overseas VC funds in order to partially meet the regulatory requirement of bringing down the promoters stake to 10%. Accordingly, the bank will issue around 56 lakh shares to WCP Holdings III and around 37 lakh shares to Tano Mauritius India FVCI II at premium of Rs33.68 per share, which has a face value of Rs10, the small-sized bank said in a statement. The stock gained 1.01% to settle at Rs44.80 on the NSE.
Natco Pharma has announced that it acquired 51% of the paid-up equity capital of Natco Organics, a joint venture between Natco Pharma and TIDCO. Natco Pharma jumped 2.935 to settle at Rs404 on the NSE.
India Infoline today said it has received approval from market regulator SEBI for launching its Alternative Investment Funds—IIFL Venture Fund, IIFL Private Equity Fund and IIFL Opportunities Fund. As part of the various asset management bouquets of products offered by the IIFL Group, India Infoline now will be additionally offering alternate asset investment products by launching various schemes, in due course, a company statement said here. The stock climbed 1.56% to settle at Rs68.20 on the NSE.


We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)